Lucid Diagnostics Inc (NAS:LUCD)
$ 0.915 0.0053 (0.58%) Market Cap: 47.68 Mil Enterprise Value: 81.10 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 16/100

Q3 2022 Lucid Diagnostics Inc Earnings Call Transcript

Nov 14, 2022 / 09:30PM GMT
Release Date Price: $2.27 (+1.79%)
Operator

Greetings, and welcome to Lucid Diagnostics Third Quarterly Update Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Adrian Miller, Vice President of Investor Relations. Thank you. You may begin.

Adrian K. Miller
Lucid Diagnostics Inc. - VP of IR

Thank you, operator. Good afternoon, everyone. This is Adrian Miller, Vice President of Investor Relations at Lucid Diagnostics. Thank you for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of Lucid Diagnostics; along with Dennis McGrath, Chief Financial Officer of Lucid Diagnostics. The press release announcing our business update and financial results will be available shortly on Lucid's website.

Please take a moment to read the disclaimers about forward-looking statements in the press release. The business update press release and the conference call, both include forward-looking statements, and these forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot